WallStSmart

Churchill Capital Corp XI Class A Ordinary Shares (CCXI)vsCal Redwood Acquisition Corp. Class A Ordinary Shares (CRAQ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CRAQ leads profitability with a 0.0% profit margin vs 0.0%. CRAQ earns a higher WallStSmart Score of 32/100 (F).

CCXI

Avoid

32

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 5.0

CRAQ

Avoid

32

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 4.7Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
549.0%10/10

Revenue surging 549.0% year-over-year

CRAQ0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-47.0%2/10

ROE of -47.0% — below average capital efficiency

Free Cash FlowQuality
$-26.53M2/10

Negative free cash flow — burning cash

CRAQ4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$398.50M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

The strongest argument for CCXI centers on Revenue Growth. Revenue growth of 549.0% demonstrates continued momentum.

Bull Case : CRAQ

CRAQ has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are EPS Growth, Profit Margin, Return on Equity.

Bear Case : CRAQ

The primary concerns for CRAQ are Revenue Growth, EPS Growth, Market Cap. A P/E of 44.4x leaves little room for execution misses.

Key Dynamics to Monitor

CCXI profiles as a hypergrowth stock while CRAQ is a value play — different risk/reward profiles.

CCXI is growing revenue faster at 549.0% — sustainability is the question.

CRAQ generates stronger free cash flow (-57,446), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (32/100 vs 32/100) and 549.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Cal Redwood Acquisition Corp. Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Cal Redwood Acquisition Corp. (CRAQ) is a special purpose acquisition company (SPAC) targeting strategic mergers with innovative firms primarily in the technology, healthcare, and consumer sectors. Led by an experienced management team with a strong track record in identifying high-growth opportunities, CRAQ aims to enhance shareholder value through a disciplined acquisition strategy. The company is dedicated to partnering with businesses that exhibit strong financial performance and the capacity for substantial innovation, positioning itself to thrive in a rapidly evolving market environment.

Want to dig deeper into these stocks?